Literature DB >> 6348957

The anemia of chronic disease.

G R Lee.   

Abstract

The anemia of chronic disease (ACD) is defined as a mild anemia associated with a chronic inflammatory, infectious or neoplastic illness and with a characteristic disturbance of iron metabolism. Many of the findings in ACD can be accounted for by release of a monokine called leukocyte endogenous mediator (LEM), endogenous pyrogen, or interleukin-1. This substance is released from "activated" monocytes. Bacterial endotoxins, certain lymphokines and phagocytic challenges are among the factors stimulating its biosynthesis. LEM induces fever, leukocytosis, biosynthesis. LEM induces fever, leukocytosis, and a variety of biochemical changes, including hypoferremia and alterations in plasma protein synthesis, collectively known as the "acute phase response." It is proposed that ACD results from the long-term elaboration of LEM and that release of this material is the common pathogenetic factor found in the illnesses that are associated with ACD. Some suggestions are made for testing the hypothesis. The hypoferremia associated with ACD is probably caused by defective release of iron from cells--particularly from macrophages, but also from hepatocytes and intestinal epithelium. Two possible mechanisms for this abnormality have been proposed: liberation of lactoferrin from neutrophilic leukocytes and induction of apoferritin synthesis. Neither mechanism has been established. Erythrokinetic studies in ACD have detected a modest reduction of erythrocyte survival without an adequate compensatory increase in the rate of red cell production. The reduced erythrocyte survival is probably related to an increase in phagocytic activity by activated macrophages. Impaired bone marrow response is partly related to the restricted iron supply, but there is substantial evidence for an additional defect in erythropoietin secretion. In some malignant diseases, there is evidence of an additional abnormality: impaired marrow response to a normal amount of erythropoietin. The nature of the erythropoietic defects and the relation of LEM to them remain to be established.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6348957

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  45 in total

Review 1.  Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease.

Authors:  R E Fleming; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

2.  Inhibition of human colony-forming-unit erythroid by tumor necrosis factor requires accessory cells.

Authors:  R T Means; E N Dessypris; S B Krantz
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

3.  Evaluation of serum transferrin receptor and sTfR ferritin indices in diagnosing and differentiating iron deficiency anemia from anemia of chronic disease.

Authors:  Shilpa Jain; Shashi Narayan; Jagdish Chandra; Sunita Sharma; Sonal Jain; Priya Malhan
Journal:  Indian J Pediatr       Date:  2010-01-20       Impact factor: 1.967

4.  Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro.

Authors:  C P Maury; L C Andersson; A M Teppo; S Partanen; E Juvonen
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

5.  Interleukin 1 administration in mice produces hypoferremia despite neutropenia.

Authors:  V R Gordeuk; P Prithviraj; T Dolinar; G M Brittenham
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 6.  Identification and treatment of anaemia in older patients.

Authors:  P T Murphy; R M Hutchinson
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

7.  Haematologic consequences of viral infections including serum iron status.

Authors:  A P Cemeroglu; S Ozsoylu
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

8.  Cisplatin-associated anemia: an erythropoietin deficiency syndrome.

Authors:  P A Wood; W J Hrushesky
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Red cell ferritin content: a re-evaluation of indices for iron deficiency in the anaemia of rheumatoid arthritis.

Authors:  A Davidson; M B Van der Weyden; H Fong; M J Breidahl; P F Ryan
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-15

10.  Serum ferritin and free erythrocyte protoporphyrin in rheumatoid arthritis.

Authors:  P Hannonen; T Möttönen; M Oka
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.